* Newstin.co.uk is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.co.uk and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.co.uk is for sale! *

Samaritan Pharmaceuticals

U.S. Patent Disclosures

of Halle, Germany, received U.S. Patent No. 7,371,404, titled "Amphoteric liposomes and their use." Oncolytics Biotech Inc., of Calgary, Alberta, was granted U.S. Patent No. 7,374,752, titled "Reovirus for the Treatment of...

Samaritan CEO Janet Greeson Honored as One of "100 of the Most Inspiring People in Life Sciences"...

Samaritan Pharmaceuticals (OTCBB:SPHC) (http://www.samaritanpharma.com), a biopharmaceutical company committed to commercializing new innovative therapeutic drugs, announced its CEO, Dr. Janet Greeson has been selected by...

Samaritan's HIV Drug Granted IND From FDA

Samaritan Pharmaceuticals (OTCBB:SPHC), a biopharmaceutical company committed to commercializing new innovative therapeutic drugs, announced that it has filed an IND (Investigational New Drug) application for SP-6310 in the...

Samaritan Pharmaceuticals announces filing of IND for SP-6310 for HIV Drug

09-Jul-2008

Samaritan Pharmaceuticals (OTCBB:SPHC), a biopharmaceutical company, said on 8 July that the company has filed an IND(Investigational New Drug) application with US Food and Drug Administration (FDA) for SP-6310, a potential...

Samaritan Pharma Receives Pricing Approval in Greece for Rapydan and Launches Novel Product

From the PharmaLive.com News Archive - Jun. 17, 2008 LAS VEGAS--(BUSINESS WIRE)--Jun 17, 2008 - Samaritan Pharmaceuticals (OTCBB:SPHC) (http://www.samaritanpharma.com), a biopharmaceutical company committed to commercializing...

Samaritan Pharmaceuticals, Inc.'s Last Ditch Salvage Therapy SP-01A Fighting HIV Drug Resistance...

Previous Page Page 1 Next Page Samaritan Pharmaceuticals, Inc.'s Last Ditch Salvage Therapy SP-01A Fighting HIV Drug Resistance Issued US Patent 10:25am EDT Samaritan Pharmaceuticals, Inc. announced its proprietary HIV drug, SP-01A, is awarded US patent No: US 7,354,906 B2, entitled “Composition...

US drug firm left waiting on $8m from Irish deal

A US drug company that signed a $10m (€6.4m) deal with Athlone firm Pharmaplaz last year is still awaiting a payment of almost $8m. A cheque for $8.6m delivered by the Irish company was returned late last year due to insufficient funds being available in the account.

Sterling-Hoffman Life Sciences Journal Spotlights CEO of Samaritan Pharma (Business Wire)

Friday May 16, 9:20 am ET "A good samaritan with an eclectic past, Dr. Janet Greeson has been a US Congressional Nominee for the State of Nevada and worked with Mother Teresa in Rome. A self-described people person, Janet gives credit to her team for Samaritan's success and believes that it takes...

Patent Claims Allowed Covering Samaritan's Alzheimer's Memory Recovery Drug In Australia

Samaritan Pharmaceuticals (OTCBB:SPHC), a biopharmaceutical company committed to commercializing new innovative therapeutic drugs, has received notification that the claims in the patent application for "Neuroprotective Spirostenol Pharmaceutical Compositions" covering Caprospinol (SP-233) have...

Stockwire.com: CHAT LIVE in the only dedicated CHAT ROOM for Samaritan Pharmaceuticals...

Stockwire.com: CHAT LIVE in the only dedicated CHAT ROOM for Samaritan Pharmaceuticals (OTCBB:SPHC) shareholders! ... AUSTIN, TX -- Studies have demonstrated Caprospinol may not only slow down Alzheimer's but may also reverse plaque-related brain injuries associated with...

1 2 next